New Jersey seeks to ban PBMs, insurers from charging higher copays than actual price of drug

A proposed bill in New Jersey would ban insurers and pharmacy benefit managers from charging a higher copay than the cash price of a medication, according to New Jersey 101.5, a local radio station.

The bill would also prohibit "gag clauses" in contracts between PBMs or insurers and pharmacies. Gag orders prevent pharmacists from notifying patients they can obtain the drug for cheaper without using insurance.  

President Donald Trump signed a bill into law last year that banned gag orders. Implementation of the law is ongoing.

The New Jersey measure was unanimously approved by the Senate in late February. It now awaits Assembly approval.

More articles on pharmacy:
Harvard gets $100M infusion for drug research from hedge fund
Purdue Pharma CEO: Bankruptcy is 'an option' amid lawsuits
Intermountain CEO Dr. Marc Harrison: How Civica Rx will disrupt the drug industry

© Copyright ASC COMMUNICATIONS 2021. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.